Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:33 PM
Ignite Modification Date:
2025-12-24 @ 2:33 PM
NCT ID:
NCT01053559
Eligibility Criteria:
Inclusion Criteria:
* Adults aged 18-70 with confirmed Crohn's disease that includes small bowel disease
* Moderately to severely active disease (CDAI score \>220 and \< 450)
* Stable doses of steroids, 5-ASA, antibiotics, Immunosuppressants
Exclusion Criteria:
* Any and all contraindications to the use of certolizumab pegol (including but not limited to hepatitis, infection, abscess, malignancy, congestive heart failure \[CHF\], cytopenia)
* Small bowel obstruction, stricture, or any contraindication for capsule endoscopy
* Previous treatment with certolizumab pegol
* Are pregnant or lactating
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01053559
Study Brief:
Protocol Section:
NCT01053559